MarketInOut Stock Screener Log In | Sign Up

Anika Therapeutics Inc

IEX • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/27/2026 15:59
Anika Therapeutics Inc stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeIEX
Market Capitalization284.12 mln
Float12.54 mln
Earnings Date10/29/2026

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-2.69
Likely reliable

Relative Strength

80 / 100
Strongly outperforming

Debt / Equity

0.18
Very low leverage

Pre-Tax Margin

-2%
Barely loss-making

ROE

-2.67
Negative

Business Description

Anika Therapeutics, founded in 1983 and based in Bedford, Massachusetts, develops products designed to protect joints and reduce the need for invasive procedures by addressing orthopedic conditions at an early stage. The company offers a range of treatments for osteoarthritis pain, including injection-based therapies and bone repair solutions, as well as products that support cartilage and tissue regeneration. Beyond orthopedics, Anika also markets treatments for surgical adhesion prevention, eye care, and joint health in horses. Its products are sold across the United States, Europe, and other international markets.

Key Fundamentals

EPS-0.23
ROE-2.67
RPS8.69
ROIC-3.90
ROA-2.01
EBITDA, mln2.72
EV / EBITDA93.79
EV / EBIT-87.48
Revenue, mln121
EV / Revenue2.11

Quote Details

Last 21.35
Change 0.12 (0.57%)
Open 21.25
Volume 51,937
Turnover 1,108,855
Average Volume 66,985

Financial Ratios

Pre-Tax Profit Margin-2
Leverage Ratio1.34
Current Ratio4.48
Price / Book1.92
Price / Tangible Book2.06
Price / Cash Flow47.64
Price / Free Cash Flow505
Debt / Equity0.18
Price / Sales2.32
PEG Ratio2.17

Financial Strength

Altman Z-Score5.03
Piotroski F-Score 6 / 9
Beneish M-Score-2.69
Price to Intrinsic Value2.54
Short Ratio4.53
Short % of Float3.60

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 4.45% 87 / 100   
1 Month 3.49% 76 / 100   
2 Months 42.24% 97 / 100   
6 Months 39.82% 93 / 100   
1 Year 113% 97 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog